Alzheimer Disease, Early Onset Clinical Trial
— HOPEOfficial title:
Effects of the Adapted Home-based Exercise Program "T&E" (Test-and-Exercise) on Balance, Mobility, and Executive Functions in Persons With Alzheimer's Disease: Protocol for an Exploratory Pilot Study
NCT number | NCT04916964 |
Other study ID # | HOPE |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | June 30, 2021 |
Est. completion date | December 30, 2021 |
The aim of this exploratory pilot study is to assess the feasibility and effectiveness of the adapted T&E home-based exercise program on the basic functional mobility and executive functions in persons with mild or probable Alzheimer's Disease.
Status | Recruiting |
Enrollment | 12 |
Est. completion date | December 30, 2021 |
Est. primary completion date | October 30, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Must living at their own home, - Clinical diagnosis of mild or probable Alzheimer's Disease, - Must be medical stable, - Must be able to walk with or without assistive device without physical assistance of another person, - Must be able to follow one-step commands, - Family caregiver's must agree to participate at the training sessions. Exclusion Criteria: - Severe vision and verbal impairment, - Any serious orthopaedic condition, - Any major neurologic or musculoskeletal comorbidity that might affect their functional mobility, - Any limiting cardiac or pulmonary condition. |
Country | Name | City | State |
---|---|---|---|
Switzerland | CMS Sierre Région | Sierre | Valais |
Lead Sponsor | Collaborator |
---|---|
HES-SO Valais-Wallis | Hilfiker Roger |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Functional mobility | Berg Balance Scale (BBS), scoring ranges from 0 (worse) to 56 (best) | 8 weeks | |
Primary | Stand and go | Time Up and Go test (TUG) in seconds | 8 weeks | |
Primary | Sit to stand | Five Time Sit to Stand (FTSTS) in seconds | 8 weeks | |
Primary | Walking speed | The self-selected and the maximal walking speed (SSWS/MWS) on a 6-meter walk | 8 weeks | |
Secondary | The Set shifting (Mental flexibility) | Trail Making Test Part-Be in seconds | 8 weeks | |
Secondary | The updating (Working memory) | Digit span backward task, number of the successful sequences between 0 and 14 | 8 weeks | |
Secondary | The response inhibition | Stroop Color and Word Test (SCWT) Victoria, comparison of the expected score to the participant's score to calculate the Z-score | 8 weeks | |
Secondary | Feasibility of recruitement | Inclusion of 12 subjects between the 30 of May 2021 ant the 30 of Septembre 2021 | 4 months | |
Secondary | Participation agreement | Fulfilled if 75% of eligible subjects agree to participate and sign the consent | 4 months | |
Secondary | Costs | Fulfilled if the cost does not exceed the planed amounts by more than 5% | 8 months | |
Secondary | Drop out / withdraw | Fulfilled if 75% of the participants take part in the total duration of the study | 8 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03625401 -
Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease
|
Phase 2 | |
Recruiting |
NCT05983575 -
A Pivotal Study of LIPUS-Brain in Patients With Early Alzheimer's Disease
|
Phase 3 | |
Completed |
NCT05989087 -
The Resting-state EEG Gamma Oscillations in Alzheimer's Disease
|
||
Recruiting |
NCT06080659 -
Network-based biOmarker Discovery of Neurodegenerative Diseases Using Multimodal Connectivity
|
N/A | |
Not yet recruiting |
NCT06099587 -
MIMA Pilot Study: MIcrostructure of the Medial Temporal Lobe in Early Alzheimer's Disease
|
N/A | |
Not yet recruiting |
NCT05604183 -
Hyperspectral Retinal Observations for the Cross-sectional Detection of Alzheimer's Disease
|
N/A | |
Withdrawn |
NCT03514875 -
Effects of Mitochondrial-targeted Antioxidant on Mild Cognitive Impairment (MCI) Patients
|
N/A | |
Recruiting |
NCT06203106 -
NYSCF Scientific Discovery Biobank
|
||
Completed |
NCT03706885 -
Efavirenz for Patients With Alzheimer's Disease
|
Phase 1 | |
Active, not recruiting |
NCT03661034 -
Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)
|
N/A | |
Not yet recruiting |
NCT05006599 -
SNIFF - 3-Week Aptar CPS Device
|
Phase 2 | |
Recruiting |
NCT02740634 -
Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study
|
N/A | |
Active, not recruiting |
NCT03069391 -
The Interactive Physical and Cognitive Exercise System
|
N/A | |
Recruiting |
NCT04701957 -
The Ketogenic Diet for Alzheimer's Disease
|
N/A | |
Recruiting |
NCT06268886 -
Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease
|
Phase 2 | |
Recruiting |
NCT04100889 -
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease
|
||
Recruiting |
NCT04656860 -
Juice Plus Supplement Clinical Trial
|
N/A | |
Recruiting |
NCT05315895 -
The Dampness Syndrome of Chinese Medicine Cohort Study
|
||
Recruiting |
NCT04804618 -
Proteomics Study of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Recruiting |
NCT04680013 -
Genetic Studies in Familial Dementia
|